If US lawmakers are unable to negotiate a deal to prevent a government shutdown by 1 October, the US Food and Drug Administration (FDA) will have to furlough almost one-fifth of its staff and halt work that could have a critical impact on medical products industries.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,